Skip to content
Cambridge
Design
Partnership
    • Consumer Healthcare
    • Consumer Technology
    • Diagnostics
    • Drug Delivery
    • FMCG
    • Industrial
    • Medical Therapy
    • Tobacco Harm Reduction
    • Applied Science
    • Data Science & Digital Service
    • Insight & Strategy
    • People-Centered Design
    • Product Engineering
    • Quality & Regulatory Affairs
    • Sustainability
    • Testing & Evaluation
    • Transfer to Manufacture
  • Our Work
  • Insights
  • How we work
  • Company
    • Benefits
    • Bourn Quarter
    • Early careers
    • Join our team
    • FAQs & top tips
    • What to expect
  • Contact

Tag: Reduced Risk Product Sign Up

Analysis

Why so few smokers have transitioned to Reduced Risk Products (and what the industry can do about it)

20 Jan 2026

This article challenges why reduced-risk products have failed to gain mass adoption, reframes the problem through smoker psychology, and proposes a strategic roadmap to accelerate meaningful tobacco harm reduction.

Analysis

Heated Tobacco: A Lukewarm Success Story

22 Sep 2025

This article explores why heated tobacco remains niche despite major investment, showing how products prioritise compliance over experience and miss the simplicity and ritual smokers want. True progress will require rethinking design, physics, and industry-wide collaboration.

Analysis

The Disposable Vapes Ban: Harming Harm Reduction

17 Jul 2025

This article explores why most smokers haven’t embraced reduced-risk products, revealing how current vape and heated tobacco tech fails to deliver the ritual, satisfaction, and simplicity smokers still seek.

Analysis

Why Have So Few Smokers Transitioned to Reduced Risk Products?

29 May 2025

This article explores why most smokers haven’t embraced reduced-risk products, revealing how current vape and heated tobacco tech fails to deliver the ritual, satisfaction, and simplicity smokers still seek.

Whitepaper

Assessing the Efficacy of THR Interventions

17 Jul 2024

This whitepaper presents the findings of our systematic review conducted with Inter Scientific, evaluating the most efficacious interventions in the complex landscape of tobacco harm reduction.

Whitepaper

Routes to success in the therapeutic cannabinoid market

1 Jul 2021

It can be extremely challenging to identify an optimum business and product strategy in the current cannabinoid market.

US OFFICE
801 West Morgan Street
Suite 120, Raleigh, NC 27603
+1 (919) 901 0909
UK OFFICE
Bourn Quarter, Wellington Way, Caldecote, Cambridge CB23 7FW
+44 (0)1223 264428
Cookie Policy | Privacy Policy | Supplier Code of Conduct
© Cambridge Design Partnership Ltd 2026. Registered in England and Wales No. GB6786351.